For retail sale medicaments with other antibiotics market in Romania

Earlier Report Observations

The market for retail sale medicaments with other antibiotics in Romania contracted from 58.8 million US dollars in 2018 to 46.6 million in 2020. Throughout this phase, the competitive landscape featured major local and international players, such as Antibiotice Iași, whose export operations across more than 55 countries imposed strict international quality and sustainability standards on the local market.

A reversal began in 2021, with market volume surging to 74.7 million US dollars. This shift coincided with Biofarm opening a new production facility and announcements of significant investments to modernize plants by key Romanian manufacturers, including Antibiotice Iași, laying the groundwork for future expansion. Growth continued to 81.3 million in 2022, supported by geopolitical uncertainties that led Antibiotice Iași to invest 100 million lei in a new plant for potassium iodide tablets, addressing specific regulatory and preparedness demands.

Following a modest correction to 74.4 million in 2023, the market leaped to 120.9 million in 2024. This jump was driven by Antibiotice Iași's planned 143 million lei investment to boost capacity for sterile and topical products, the launch of 15 new products for the domestic market, and a 25% rise in the company's export revenue. Concurrently, the completion of Stada's new plant in Turda, alongside the expansion of the OTC segment and an aging population, bolstered local consumption.

Production for retail sale medicaments with other antibiotics in Romania

In value, 2017-2020, K $ US

Romania's production of retail sale medicaments containing other antibiotics has grown for the third consecutive year. In 2020, output was valued at 44 005 thousand US dollars, remaining broadly stable compared to the previous year. Between 2017 and 2020, production increased by 26.4%, which translates to an annualized growth rate of 8.1%.

Annual dynamics of production in Romania in value, 2017-2020, K $ US

Exports for retail sale medicaments with other antibiotics from Romania

Exports in kind, t

Romania's exports of retail sale medicaments with other antibiotics have risen for the third year in a row. In 2020, the country shipped 1 078 tonnes abroad, marking a slight uptick of 1.7% from the previous year. From 2017 to 2020, exports grew by 18.7%, equating to an annualized rate of 5.9%.

Annual dynamics of product's exports from Romania in kind, 2017-2020, t

Between 2017 and 2020, Romania's exports of these medicaments in kind were scattered across multiple countries. The United States accounted for 16.4% of exports, the United Kingdom for 10.7%, and Germany for 9.1%. Together, these three partners represented just 36.2% of total flows, with no single country emerging as clearly dominant.

Structure of product's exports in kind by countries, 2017-2020

World map of product's exports from Romania in kind, 2017-2020

Exports in value, K $ US

In 2020, Romania's exports of retail sale medicaments with other antibiotics reached 79 621 thousand US dollars, up by 3.8% year-over-year. Between 2017 and 2020, exports increased by 19.2%, corresponding to an annualized growth rate of 6.0%. The largest decline occurred in 2019, at 1.5%, while the largest increase was recorded in 2018, at 16.5%.

Annual dynamics of product's exports from Romania in value, 2017-2020, K $ US

From 2017 to 2020, the United States and Germany each accounted for 11.6% of Romania's exports in value terms, followed by the United Kingdom at 6.6%. However, even combined, these three largest buyers represented only 29.8% of total exports, indicating a broadly diversified partner base for these medicaments.

Structure of product's exports in value by countries, 2017-2020

World map of product's exports from Romania in value, 2017-2020

Imports for retail sale medicaments with other antibiotics to Romania

Imports in kind, t

Romania imported approximately 1 342 tonnes of retail sale medicaments with other antibiotics in 2020, reflecting a moderate increase of 5.3% over the past year. Between 2017 and 2020, imports rose by 2.3%, which equates to an annualized rate of 0.8%. The lowest volume was recorded in 2019 at 1 274 tonnes, with the largest decline that year at 3.4%.

Annual dynamics of product's imports to Romania in kind, 2017-2020, t

Over the period 2017–2020, imports in kind of these medicaments to Romania were widely dispersed across partner countries. China led with 17.0% of imports, followed by Slovenia at 12.4% and Italy at 12.3%. Together, these three countries accounted for only 41.7% of total flows.

Structure of product's imports in kind by countries, 2017-2020

World map of product's imports to Romania in kind, 2017-2020

Imports in value, K $ US

Cross-border shipments of retail sale medicaments with other antibiotics to Romania declined for the second consecutive year. In 2020, imports totaled 91 000 thousand US dollars, down by 4.2% compared to the previous year. From 2017 to 2020, imports decreased by 9.1%, with a compound annual growth rate of -3.1%. The highest value was recorded in 2018 at 95 798 thousand US dollars, with the largest decline in 2019 at 10.5% and the largest increase in 2018 at 6.0%.

Annual dynamics of product's imports to Romania in value, 2017-2020, K $ US

Between 2017 and 2020, imports in value terms of these medicaments to Romania were not heavily concentrated. Belgium accounted for 13.3% of imports, Italy for 12.0%, and the United Kingdom for 10.1%. Together, these three partners captured only 35.4% of total flows.

Structure of product's imports in value by countries, 2017-2020

World map of product's imports to Romania in value, 2017-2020